Hood Brian L, Darfler Marlene M, Guiel Thomas G, Furusato Bungo, Lucas David A, Ringeisen Bradley R, Sesterhenn Isabell A, Conrads Thomas P, Veenstra Timothy D, Krizman David B
Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute, Frederick, MD 21702, USA.
Mol Cell Proteomics. 2005 Nov;4(11):1741-53. doi: 10.1074/mcp.M500102-MCP200. Epub 2005 Aug 9.
Proteomic analysis of formalin-fixed paraffin-embedded (FFPE) tissue would enable retrospective biomarker investigations of this vast archive of pathologically characterized clinical samples that exist worldwide. These FFPE tissues are, however, refractory to proteomic investigations utilizing many state of the art methodologies largely due to the high level of covalently cross-linked proteins arising from formalin fixation. A novel tissue microdissection technique has been developed and combined with a method to extract soluble peptides directly from FFPE tissue for mass spectral analysis of prostate cancer (PCa) and benign prostate hyperplasia (BPH). Hundreds of proteins from PCa and BPH tissue were identified, including several known PCa markers such as prostate-specific antigen, prostatic acid phosphatase, and macrophage inhibitory cytokine-1. Quantitative proteomic profiling utilizing stable isotope labeling confirmed similar expression levels of prostate-specific antigen and prostatic acid phosphatase in BPH and PCa cells, whereas the expression of macrophage inhibitory cytokine-1 was found to be greater in PCa as compared with BPH cells.
对福尔马林固定石蜡包埋(FFPE)组织进行蛋白质组学分析,将能够对全球存在的大量经过病理特征分析的临床样本档案进行回顾性生物标志物研究。然而,这些FFPE组织很难采用许多先进方法进行蛋白质组学研究,这主要是由于福尔马林固定导致的高水平共价交联蛋白质。一种新型组织显微切割技术已经开发出来,并与一种直接从FFPE组织中提取可溶性肽以用于前列腺癌(PCa)和良性前列腺增生(BPH)质谱分析的方法相结合。从PCa和BPH组织中鉴定出了数百种蛋白质,包括几种已知的PCa标志物,如前列腺特异性抗原、前列腺酸性磷酸酶和巨噬细胞抑制细胞因子-1。利用稳定同位素标记的定量蛋白质组学分析证实,BPH和PCa细胞中前列腺特异性抗原和前列腺酸性磷酸酶的表达水平相似,而与BPH细胞相比,巨噬细胞抑制细胞因子-1在PCa中的表达更高。